As researchers continue to test the efficacy of the bivalent boosters and COVID-19 treatments, about 3 in 4 COVID-19 infections are from omicron subvariants BQ.1.1, BQ.1 and XBB, CDC data shows.
Read the full post on Becker's Hospital Review - Healthcare News
